Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • pyridine
    Member
    • Jun 2013
    • 11

    hybridization of custom low concentration ssDNA library

    I've been preparing libraries enriched for transposon-chromosome junctions using a sub-optimal non-kit procedure which gives me extremely low concentrations of ssDNA in the 200-1000 pM range, as determined by qPCR. To clarify, the final library is already in ssDNA form because there is an affinity capture step of biotinylated PCR product in the last part of the preparation on streptavidin beads, and denaturation is performed on the beads to elute the complementary strand. The final ssDNA product is then column-purified and eluted in 10 mM Tris-Cl pH 8.5.

    The first time I performed this procedure, I had somewhat higher concentrations of each library (2.4 to 11.8 nM), and was able to successfully skip to pooling the 4 libraries directly in a 12 uL total volume, then take 3 uL of this, add 3 uL of 0.2 N NaOH, and proceed with the dilution to 10 pM in hybridization buffer as usual. This gave a good enough distribution of reads between each of the 4 indices, ranging between 16 and 24% of reads each on a MiSeq.

    This time I'm trying to scale up the procedure and pool 8 libraries that are at a lower concentration, so it will not be possible for me to prepare the dilution that is denatured with an equal volume of 0.2 N NaOH. I can however, still dilute the libraries directly to a total pooled concentration of 8-10 pM in hybridization buffer (HT1), albeit with errors introduced from pipetting small volumes. My question is if the denaturation step is still necessary if the library is already ssDNA?

    Also does anyone have experience reducing from 10 pM to 8 pM concentration in buffer HT1?

    Thanks for any tips.
  • kcchan
    Senior Member
    • Jul 2012
    • 186

    #2
    You can always heat denature your samples just to be safe. Dilute your libraries in HT1 to the desired concentration and incubate it at 95°C for a minute or so and immediately place it on ice. Once the tube has cooled down you can load it on the MiSeq.

    Comment

    • pyridine
      Member
      • Jun 2013
      • 11

      #3
      Thanks for your reply. I'm glad to hear it suggested from someone else, since that was also what we decided to do. I'll know if it works later today. It will be a bit shy of a 1:100 dilution (8 uL library in 592 uL) but hopefully that will be too little difference to matter.

      It seems that the low concentrations were low due to poor efficiency of the PCR enrichment this time around.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...